A biotech with 100% upside keeps reporting safe results, Evercore says

Nov. 03, 2021 9:35 AM ETCABABy: Jason Aycock, SA News Editor4 Comments

T-Cells Work to Fight Cancer, Immunotherapy, CAR T-cell therapy, 3d renderin

Design Cells/iStock via Getty Images

  • A clinical update from a biotech working on T-cell therapies has Evercore ISI reiterating a price target that's the highest on Wall Street.
  • No dose-limiting toxicities or clinically relevant adverse events were reported by

Recommended For You

Comments (4)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.